Articles by National Institute of Health

The National Institutes of Health awarded nearly $470 million to build a study on the long-term effects of COVID-19

Study lays the groundwork for potential new therapies for progressive multiple sclerosis

These insights will help unlock the mystery of how lung cancer arises in people who have no history of smoking

The “Imbokodo” clinical trial posed no safety concerns but did not provide sufficient protection against HIV infection

Neurofibromatosis type 1, or NF1, is the most common cancer predisposition syndrome

Trial also will test pausing immunosuppressive medication to improve antibody response

The new method bypasses extraction of the virus’ genetic RNA material, simplifying sample purification

Recommendations aim to help streamline research and optimize clinical care

Full-dose blood thinners reduce the need for organ support in moderately ill COVID-19 patients

Outreach Pro aimed at increasing underrepresented population participation

Presence of certain features on CT scans may guide follow-up treatment

Overall incidence rates continue to increase in women, children and adolescents and young adults

COVID-19 Testing initiative funds five additional projects to identify ways of safely returning to in-person schools

Challenge put out for researchers to design a method for analyzing a large data set of first-time pregnancies

New study has found that SARS-CoV-2 does not appear to pose a threat to the safety of the nation’s blood supply